Copyright ©The Author(s) 2018.
World J Gastroenterol. Sep 7, 2018; 24(33): 3681-3694
Published online Sep 7, 2018. doi: 10.3748/wjg.v24.i33.3681
Table 1 Fecal calprotectin cut off values and performance in different populations
Ref.Patients and disease (n)Cut-offSensitivity (%)Specificity (%)
Lin et al[23]1471 IBD (active vs inactive)50 μg/g9260
100 μg/g8466
150 μg/g8082
Limburg et al[24]110 patients with chronic diarrhea (prediction of inflammation)100 μg/g8383
Von Roon et al[25]IBD vs no IBD
126750 μg/g8981
328100 μg/g9891
D’Haens et al[27]126 IBD (large ulcers)250 μg/g60.479.5
87 CD (Endoscopic remission)250 μg/g9462.2
39 UC (Active mucosal disease)
250 μg/g71100
Sipponen et al[29]77 CD (active vs inactive)50 μg/g9144
100 μg/g8169
200 μg/g7092
Kittanakom et al[21]40 inactive pediatric CD (prediction of relapse)400 μg/g10075.9
(PhiCal Calprotectin - EIA)
500 μg/g (Buhlmann POCT)
800 μg/g10075.9
Vazquez Moron et al[31]71 CD (active vs inactive)170 μg/g77.695.5